Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
1ottrunner
X
View Profile
View Bullboard History
Post by
1ottrunner
on Mar 20, 2023 1:47pm
Cool888
How about now? Imagine if you had all taken your money out of this and bought btc like a mentioned a few months the ago. Good luck all. Cool, which of us is the fool?
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Mar 20, 2023 9:41am
RE:$RVV Update
cool, its time now you call michael frank to resign
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 20, 2023 8:41am
$RVV Update
https://finance.yahoo.com/news/revive-therapeutics-provides-phase-3-122800259.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 20, 2023 8:28am
New Press Release - Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, March 20, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today an update on...
read article.
(26)
•••
hashboy18
X
View Profile
View Bullboard History
Comment by
hashboy18
on Mar 18, 2023 7:14pm
RE:RE:when zero
looks like its going to zero,another mucheal frank promo gone bust
(1)
•••
SecurityNetwork
X
View Profile
View Bullboard History
Comment by
SecurityNetwork
on Mar 16, 2023 11:27pm
RE:when zero
penny stock hustler team
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 16, 2023 3:51pm
FDA advisers vote in favor of full approval 4 Pfizer's pill
OMG !! https://www.xm.com/research/markets/allNews/reuters/us-fda-advisers-vote-in-favor-of-full-approval-for-pfizers-covid-pill-paxlovid-53502217
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 14, 2023 9:29pm
Veru to proceed with late-stage study of COVID pill !
#Bucillamine Interesting Article ! https://ca.sports.yahoo.com/news/veru-proceed-stage-study-covid-173832470.html
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 13, 2023 10:19am
$RVV next? #Bucillamine
$PFE acquiring $SGEN for $43 Billions Sanofi acquiring $PRVB for $2.9 Billions
(618)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Mar 13, 2023 9:08am
In the red zone !
and If over the line into the end zone ?? BUYOUT very likely !!!
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Mar 10, 2023 7:12am
Creep
The 2 month purchasing has ceased....now starts the creep and the BO offer.
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 09, 2023 9:02pm
$RVV - Looking very promising & Very soon per BMT !
#Bucillamine https://www.reddit.com/r/RVVTF/comments/11lvld1/revive_therapeutics_provides_update_from_type_c/
(618)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Mar 08, 2023 9:30am
Huh ?
Market will have to figure it out when the FDA is tired of your face they slam the door shut NO DOOR SLAMMING HERE !!! Just need to walk through and a whole new set of dynamics will unfold !!!
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Mar 08, 2023 8:17am
End Points Accepted
End Points Accepted in principle by the FDA!!!!! Based on the stat analysis of the 210! Excellent!!!
(5)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 08, 2023 7:51am
$RVV - Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-provides-type-c-124500307.html
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >